UCB SA
ENXTBRUCB cost to borrow surges to 1.94%, up 219% in one week as short-covering demand intensifies on the Brussels-listed pharma name.
Snapshot as of 26 Sept 2026
No long-form analysis yet for UCB. Pulse alerts and the live data picture are available on ORTEX.
Open UCB on ORTEX →Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for UCB — free to start on ORTEX.
Sign up for free →Open UCB on ORTEX